Molecular structure and physiological functions of GABAB receptors

Physiological Reviews

Volumn 84, Issue 3, 2004, Pages 835-867

  Bettler, Bernhard ^a   Kaupmann, Klemens ^a   Mosbacher, Johannes ^a   Gassmann, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; [3 (3,4 DICHLOROBENZYLAMINO)PROPYL](DIETHOXYMETHYL)PHOSPHINIC ACID; BACLOFEN; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CGP 13501; CGP 44532; CGP 7930; COMPLEMENTARY DNA; DIMER; G PROTEIN COUPLED RECEPTOR; GS 39783; UNCLASSIFIED DRUG;

ALLOSTERISM; CHEMICAL STRUCTURE; EPILEPSY; GABAERGIC SYSTEM; GENETIC POLYMORPHISM; HUMAN; LOCOMOTION; MENTAL DISEASE; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOTOR DYSFUNCTION; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CLONING, MOLECULAR; EPILEPSY; GASTROINTESTINAL DISEASES; HUMANS; LINKAGE (GENETICS); MOLECULAR STRUCTURE; NOCICEPTORS; RECEPTORS, GABA-B; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANCE-RELATED DISORDERS;

EID: 3042546515     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00036.2003     Document Type: Review

References (356)

1. Abdalla S, Lother H, and Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407: 94-98, 2000.
2. B-R1 receptors in serotonergic neurons: effects of baclofen on 5-HT output in rat brain. Neuroreport 11: 941-945, 2000.
3. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, and Gasbarrini G. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol 37: 504-508, 2002.
4. Amico C, Marchetti C, Nobile M, and Usai C. Pharmacological types of calcium channels and their modulation by baclofen in cerebellar granules. J Neurosci 15: 2839-2848, 1995.
5. Anaya M, Romero T, Sofia RD, and Yunis EJ. Linkage disequilibrium of HLA-A11 and A1 with one of the polymorphisms of the gamma-aminobutyric acid receptor type B. Tissue Antigens 58: 324-328, 2001.
6. Andriamampandry C, Taleb O, Viry S, Muller C, Humbert JP, Gobaille S, Aunis D, and Maitre M. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB J 17: 1691-1693, 2003.
7. Angers S, Salahpour A, and Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42: 409-435, 2002.
8. Armstrong N, Sun Y, Chen GQ, and Gouaux E. Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 395: 913-917, 1998.
9. Asano T and Ogasawara N. Uncoupling of gamma-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: effect of N-ethylmaleimide on purified GTP-binding proteins. Mol Pharmacol 29: 244-249, 1986.
10. Asano T, Ui M, and Ogasawara N. Prevention of the agonist binding to gamma-aminobutyric acid B receptors by guanine nucleotides and islet-activating protein, pertussis toxin, in bovine cerebral cortex. Possible coupling of the toxin-sensitive GTP-binding proteins to receptors. J Biol Chem 260: 12653-12658, 1985.
11. Azatian KV, Ayrapetyan SN, and Carpenter DO. Metabotropic GABA receptors regulate acetylcholine responses on snail neurons. Gen Pharmacol 29: 67-72, 1997.
12. Bai D and Sattelle D. A GABA-B receptor on an identified insect motor neurone. J Exp Biol 198: 889-894, 1995.
13. Balerio GN and Rubio MC. Baclofen analgesia: involvement of the GABAergic system. Pharmacol Res 46: 281-286, 2002.
14. Bamber BA, Beg AA, Twyman RE, and Jorgensen EM. The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor. J Neurosci. 19: 5348-5359, 1999.
15. Banerjee PK and Snead OC III. Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acid-B (GABA-B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. J Pharmacol Exp Ther 273: 1534-1543, 1995.
16. Barthel F, Kienlen Campard P, Demeneix BA, Feltz P, and Loeffler JP. GABA-B receptors negatively regulate transcription in cerebellar granular neurons through cyclic AMP responsive element binding protein-dependent mechanisms. Neuroscience 70: 417-427, 1996.
17. Becamel C, Figge A, Poliak S, Dumuis A, Peles E, Bockaert J, Lubbert H, and Ullmer C. Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1. J Biol Chem 276: 12974-12982, 2001.
18. Becher A, White JH, and McIlhinney RA. The gamma-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J Neurochem 79: 787-795, 2001.
19. Belley M, Sullivan R, Reeves A, Evans J, O'Neill G, and Ng GY. Synthesis of the nanomolar photoaffinity GABA-B receptor ligand CGP71872 reveals diversity in the tissue distribution of GABA-B receptor forms. Bioorg Med Chem 7: 2697-2704, 1999.
20. Benes FM and Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25: 1-27, 2001.
21. Benke D, Honer M, Michel C, Bettler B, and Mohler H. Gamma-aminobutyric acid type B receptor splice variant proteins GBR1a and GBR1b are both associated with GBR2 in situ and display differential regional and subcellular distribution. J Biol Chem 274: 27323-27330, 1999.
22. Benke D, Michel C, and Mohler H. Structure of GABA-B receptors in rat retina. J Recept Signal Transduct Res 22: 253-266, 2002.
23. Benzing T, Yaffe MB, Arnould T, Sellin L, Schermer B, Schilling B, Schreiber R, Kunzelmann K, Leparc GG, Kim E, and Walz G. 14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J Biol Chem 275: 28167-28172, 2000.
24. Bernasconi R, Mathivet P, Bischoff S, and Marescaux C. Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Trends Pharmacol Sci 20: 135-141, 1999.
25. Berthele A, Platzer S, Weis S, Conrad B, and Tolle TR. Expression of GABA-B1 and GABA-B2 mRNA in the human brain. Neuroreport 12: 3269-3275, 2001.
26. Bertrand S, Ng GY, Purisai MG, Wolfe SE, Severidt MW, Nouel D, Robitaille R, Low MJ, O'Neill GP, Metters K, Lacaille JC, Chronwall BM, and Morris SJ. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J Pharmacol Exp Ther 298: 15-24, 2001.
27. 2+ channels via GABA-B receptors in hippocampal pyramidal cells. Synapse 50: 95-109, 2003.
28. Bettler B, Kaupmann K, and Bowery N. GABA-B receptors: drugs meet clones. Curr Opin Neurobiol 8: 345-350, 1998.
29. Billinton A, Ige AO, Bolam JP, White JH, Marshall FH, and Emson PC. Advances in the molecular understanding of GABA-B receptors. Trends Neurosci 24: 277-282, 2001.
30. Billinton A, Ige AO, Wise A, White JH, Disney GH, Marshall FH, Waldvogel HJ, Faull RL, and Emson PC. Gaba-B receptor heterodimer-component localisation in human brain. Brain Res 77: 111-124, 2000.
31. Billinton A, Stean TO, Bowery NG, and Upton N. Gaba-B1 splice variant mRNAs are differentially affected by electroshock induced seizure in rats. Neuroreport 11: 3817-3822, 2000.
32. Billinton A, Upton N, and Bowery NG. Gaba-B receptor isoforms forms GBR1a and GBR1b, appear to be associated with pre- and postsynaptic elements respectively in rat and human cerebellum. Br J Pharmacol 126: 1387-1392, 1999.
33. Bischoff S, Leonhard S, Reymann N, Schuler V, Shigemoto R, Kaupmann K, and Bettler B. Spatial distribution of GABA-BR1 receptor mRNA and binding sites in the rat brain. J Comp Neurol 412: 1-16, 1999.
34. Blackshaw LA, Smid SD, O'Donnell TA, and Dent J. Gaba-B receptor-mediated effects on vagal pathways to the lower oesophageal sphincter and heart. Br J Pharmacol 130: 279-288, 2000.
35. Blahos J II, Mary S, Perroy J, De Colle C, Brabet I, Bockaert J, and Pin JP. Extreme C terminus of G protein alpha-subunits contains a site that discriminates between Gi-coupled metabotropic glutamate receptors. J Biol Chem 273: 25765-25769, 1998.
36. Blaxter TJ, Carlen PL, Davies MF, and Kujtan PW. Gamma-aminobutyric acid hyperpolarizes rat hippocampal pyramidal cells through a calcium-dependent potassium conductance. J Physiol 373: 181-194, 1986.
37. Bolser DC, Blythin DJ, Chapman RW, Egan RW, Hey JA, Rizzo C, Kuo SC, and Kreutner W. The pharmacology of SCH 50911: a novel, orally-active GABA-B receptor antagonist. J Pharmacol Exp Ther 274: 1393-1398, 1995.
38. Bonanno G, Carita F, Cavazzani P, Munari C, and Raiteri M. Selective block of rat and human neocortex GABA-B receptors regulating somatostatin release by a GABA-B antagonist endowed with cognition enhancing activity. Neuropharmacology 38: 1789-1795, 1999.
39. Bonanno G, Fassio A, Sala R, Schmid G, and Raiteri M. Gaba-B receptors as potential targets for drugs able to prevent excessive excitatory amino acid transmission in the spinal cord. Eur J Pharmacol 362: 143-148, 1998.
40. Bonanno G, Fassio A, Schmid G, Severi P, Sala R, and Raiteri M. Pharmacologically distinct GABA-B receptors that mediate inhibition of GABA and glutamate release in human neocortex. Br J Pharmacol 120: 60-64, 1997.
41. Bonanno G and Raiteri M. Multiple GABA-B receptors. Trends Pharmacol Sci 14: 259-261, 1993.
42. Bourne HR and Nicoll R. Molecular machines integrate coincident synaptic signals. Cell 72: 65-75, 1993.
43. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2: 274-286, 2001.
44. Bowery NG. Gaba-B receptor pharmacology. Annu Rev Pharmacol Toxicol 33: 109-147, 1993.
45. Bowery NG Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, and Enna SJ. International Union of Pharmacology XXXIII. Mammalian gamma-aminobutyric acid B receptors: structure and function. Pharmacol Rev 54: 247-264, 2002.
46. Bowery NG, Hill DR, Hudson AL, Doble A, Middlemiss DN, Shaw J, and Turnbull M. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 283: 92-94, 1980.
47. Brauner-Osborne H, Jensen AA, Sheppard PO, Brodin B, Krogsgaard-Larsen P, and O'Hara P. Cloning and characterization of a human orphan family C G-protein coupled receptor GPRC5D. Biochim Biophys Acta 1518: 237-248, 2001.
48. Brauner-Osborne H, Jensen AA, Sheppard PO, O'Hara P, and Krogsgaard-Larsen P. The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 274: 18382-18386, 1999.
49. Brauner-Osborne H and Krogsgaard-Larsen P. Functional pharmacology of cloned heterodimeric GABA-B receptors expressed in mammalian cells. Br J Pharmacol 128: 1370-1374, 1999.
50. Brauner-Osborne H and Krogsgaard-Larsen P. Sequence and expression pattern of a novel human orphan G-protein-coupled receptor, GPRC5B, a family C receptor with a short amino-terminal domain. Genomics 65: 121-128, 2000.
51. Brebner K, Froestl W, and Roberts DC. The GABA-B antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat. Psychopharmacology 160: 49-55, 2002.
52. Brebner K, Phelan R, and Roberts DC. Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 66: 857-862, 2000.
53. Brody DL and Yue DT. Relief of G-protein inhibition of calcium channels and short-term synaptic facilitation in cultured hippocampal neurons. J Neurosci 20: 889-898, 2000.
54. Calver A, Michalovich D, Testa T, Robbins JM, Jaillard C, Hill J, Szekeres PG, Charles KJ, Jourdain S, Holbrook JD, Boyfield I, Patel N, Medhurst AD, and Pangalos M. Molecular cloning and characterisation of a novel GABA-B related G-protein coupled receptor. Mol Brain Res 110: 305-317, 2003.
55. Calver AR, Davies CH, and Pangalos M. Gaba-B receptors: from monogamy to promiscuity. Neurosignals 11: 299-314, 2002.
56. Calver AR, Medhurst AD, Robbins MJ, Charles KJ, Evans ML, Harrison DC, Stammers M, Hughes SA, Hervieu G, Couve A, Moss SJ, Middlemiss DN, and Pangalos MN. The expression of GABA-B1 and GABA-B2 receptor subunits in the CNS differs from that in peripheral tissues. Neuroscience 100: 155-170, 2000.
57. Calver AR, Robbins MJ, Cosio C, Rice SQ, Babbs AJ, Hirst WD, Boyfield I, Wood MD, Russell RB, Price GW, Couve A, Moss SJ, and Pangalos MN. The C-terminal domains of the GABA-B receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J Neurosci 21: 1203-1210, 2001.
58. Campbell UC, Lac ST, and Carroll ME. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143: 209-214, 1999.
59. 2+ currents in rat sensory neurones by the G protein G(o): antisense oligonucleotide studies. J Physiol 470: 1-11, 1993.
60. Cange L, Johnsson E, Rydholm H, Lehmann A, Finizia C, Lundell L, and Ruth M. Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease. Aliment Pharmacol Ther 16: 869-873, 2002.
61. Cardozo DL and Bean BP. Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABA-B receptors. J Neurophysiol 74: 1137-1148, 1995.
62. Carroll FY, Stolle A, Beart PM, Voerste A, Brabet I, Mauler F, Joly C, Antonicek H, Bockaert J, Muller T, Pin JP, and Prezeau L. Bay36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol Pharmacol 59: 965-973, 2001.
63. Castelli MP, Ferraro L, Mocci I, Carta F, Carai MAM, Antonelli T, Tanganelli S, Cignarella G, and Gessa GL. Selective γ-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of γ-hydroxybutyric acid. J Neurochem 203: 722-732, 2003
64. Castelli MIP, Ingianni A, Stefanini E, and Gessa GL. Distribution of GABA-B receptor mRNAs in the rat brain and peripheral organs. Life Sci 64: 1321-1328, 1999.
65. Chan PK, Leung CK, and Yung WH. Differential expression of pre- and postsynaptic GABA-B receptors in rat substantia nigra pars reticulata neurones. Eur J Pharmacol 349: 187-197, 1998.
66. 2+-sensing receptor mediate efficient coupling to phospholipase C. J Biol Chem 275: 19955-19963, 2000.
67. Chapman RW, Hey JA, Rizzo CA, and Bolser DC. Gaba-B receptors in the lung. Trends Pharmacol Sci 14: 26-29, 1993.
68. Charara A, Heilman TC, Levey AI, and Smith Y. Pre- and postsynaptic localization of GABA-B receptors in the basal ganglia in monkeys. Neuroscience 95: 127-140, 2000.
69. Charles KJ, Calver A, Jourdain S, and Pangalos M. Distribution of a GABA-B-like receptor protein in the rat central nervous system. Brain Res 989: 135-146, 2003.
70. Charles KJ, Deuchars J, Davies CH, and Pangalos MN. Gaba-B receptor subunit expression in glia. Mol Cell Neurosci 24: 214-223, 2003.
71. Charles KJ, Evans ML, Robbins MjJ, Calver AR, Leslie RA, and Pangalos MN. Comparative immunohistochemical localisation of GABA-B1a, GABA-B1b and GABA-B2 subunits in rat brain, spinal cord and dorsal root ganglion. Neuroscience 106: 447-467, 2001.
72. Cheng Y and Lotan R. Molecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptor. J Biol Chem 273: 35008-35015, 1998.
73. Chieng B and Bekkers JM. Gaba-B, opioid and alpha2 receptor inhibition of calcium channels in acutely-dissociated locus coeruleus neurones. Br J Pharmacol 127: 1533-1538, 1999.
74. Chronwall BM, Davis TD, Severidt MW, Wolfe SE, McCarson KE, Beatty DM, Low MJ, Morris SJ, and Enna SJ. Constitutive expression of functional GABA-B receptors in mIL-tsA58 cells requires both GABA-B1 and GABA-B2 genes. J Neurochem 77: 1237-1247, 2001.
75. Clark JA, Mezey E, Lam AS, and Bonner TI. Distribution of the GABA-B receptor subunit gb2 in rat CNS. Brain Res 860: 41-52, 2000.
76. Colmers WF and Williams JT. Pertussis toxin pretreatment discriminates between pre- and postsynaptic actions of baclofen in rat dorsal raphe nucleus in vitro. Neurosci Lett 93: 300-306, 1988.
77. Colombo G, Agabio R, Carai MA, Lobina C, Pani M, Reali R, Addolorato G, and Gessa GL. Ability of baclofen in reducing alcohol intake and withdrawal severity: preclinical evidence. Alcohol Clin Exp Res 24: 58-66, 2000.
78. Connor M, Schuller A, Pintar JE, and Christie MJ. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B 16/J mice and mutant mice lacking MOR-1. Br J Pharmacol 126: 1553-1558, 1999.
79. Cousins MS, Roberts DC, and De Wit H. Gaba-B receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65: 209-220, 2002.
80. Couve A, Filippov AK, Connolly CN, Bettler B, Brown DA, and Moss SJ. Intracellular retention of recombinant GABA-B receptors. J Biol Chem 273: 26361-26367, 1998.
81. Couve A, Kittler JT, Uren JM, Calver AR, Pangalos MN, Walsh FS, and Moss SJ. Association of GABA-B receptors and members of the 14-3-3 family of signaling proteins. Mol Cell Neurosci 17: 317-328, 2001.
82. Couve A, Thomas P, Calver AR, Hirst WD, Pangalos MN, Walsh FS, Smart TG, and Moss SJ. Cyclic AMP-dependent protein kinase phosphorylation facilitates GABA-B receptor-effector coupling. Nat Neurosci 5: 415-424, 2002.
83. Crunelli V and Leresche N. A role for GABA-B receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci 14: 16-21, 1991.
84. Cui JG, Meyerson BA, Sollevi A, and Linderoth B. Effect of spinal cord stimulation on tactile hypersensitivity in mononeuropathic rats is potentiated by simultaneous GABA-B and adenosine receptor activation. Neurosci Lett 247: 183-186, 1998.
85. Cunningham MD and Enna SJ. Evidence for pharmacologically distinct GABA-B receptors associated with cAMP production in rat brain. Brain Res 720: 220-224, 1996.
86. Daoust M, Saligaut C, Lhuintre JP, Moore N, Flipo JL, and Boismare F. Gaba transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol 4: 469-472, 1987.
87. Davies CH, Starkey SJ, Pozza MF, and Collingridge GL. Gaba autoreceptors regulate the induction of LTP. Nature 349: 609-611, 1991.
88. Deisz RA, Billard JM, and Zieglgansberger W. Presynaptic and postsynaptic GABA-B receptors of neocortical neurons of the rat in vitro: differences in pharmacology and ionic mechanisms. Synapse 25: 62-72, 1997.
89. + channels underlying slow IPSCs in rat hippocampal neurons. J Neurophysiol 77: 2202-2208, 1997.
90. Devlin CL. The pharmacology of gamma-aminobutyric acid and acetylcholine receptors at the echinoderm neuromuscular junction. J Exp Biol 204: 887-896, 2001.
91. Devlin CL and Schlosser W. Gamma-aminobutyric acid modulation of acetylcholine-induced contractions of a smooth muscle from an echinoderm (Sclerodactyla briareus). Invert Neurosci 4: 1-8, 1999.
92. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, and Ashby CR Jr. A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31: 76-86, 1999.
93. Dewey SL, Morgan AE, Ashby CR, Horan B Jr, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, and Brodie JD. A novel strategy for the treatment of cocaine addiction. Synapse 30: 119-129, 1998.
94. Dicpinigaitis PV, Dobkin JB, Rauf K, and Aldrich TK. Inhibition of capsaicin-induced cough by the gamma-aminobutyric acid agonist baclofen. J Clin Pharmacol 38: 364-367, 1998.
95. Durkin MM, Gunwaldsen CA, Borowsky B, Jones KA, and Branchek TA. An in situ hybridization study of the distribution of the GABA-B2 protein mRNA in the rat CNS. Brain Res 71: 185-200, 1999.
96. Dutar P and Nicoll RA. Pre- and postsynaptic GABA-B receptors in the hippocampus have different pharmacological properties. Neuron 1: 585-591, 1988.
97. Duthey B, Caudron S, Perroy J, Bettler B, Fagni L, Pin JP, and Prezeau L. A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA-B receptor. J Biol Chem 277: 3236-3241, 2002.
98. Easter A and Spruce AE. Recombinant GABA-B receptors formed from GABA-B1 and GABA-B2 subunits selectively inhibit N-type Ca(2+) channels in NG108-15 cells. Eur J Pharmacol 440: 17-25, 2002.
99. Erhardt S, Mathe JM, Chergui K, Engberg G, and Svensson TH. Gaba-B receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn-Schmiedebergs Arch Pharmacol 365: 173-180, 2002.
100. Filippov AK, Couve A, Pangalos MN, Walsh FS, Brown DA, and Moss SJ. Heteromeric assembly of GABA-BR1 and GABA-BR2 receptor subunits inhibits Ca(2+) current in sympathetic neurons. J Neurosci 20: 2867-2874, 2000.
101. Fischer Y and Parnas I. Activation of GABA-B receptors at individual release boutons of the crayfish opener neuromuscular junction produces presynaptic inhibition. J Neurophysiol 75: 1377-1385, 1996.
102. Francesconi A and Duvoisin RM. Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J Biol Chem 273: 5615-5624, 1998.
103. Franek M, Pagano A, Kaupmann K, Bettler B, Pin JP, and Blahos J. The heteromeric GABA-B receptor recognizes G-protein alpha subunit C-termini. Neuropharmacology 38: 1657-1666, 1999.
104. Fritschy JM, Meskenaite V, Weinmann O, Honer M, Benke D, and Möhler H. Gaba-B receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular distribution and extrasynaptic localization. Eur J Neurosci 11: 761-768, 1999.
105. Fromm GH. The pharmacology of trigeminal neuralgia. Clin Neuropharmacol 12: 185-194, 1989.
106. Furtinger S, Bettler B, and Sperk G. Altered expression of GABA-B receptors in the hippocampus after kainic-acid-induced seizures in rats. Brain Res 113: 107-115, 2003.
107. Futatsugi Y and Riviello JJ. Mechanisms of generalized absence epilepsy. Brain Dev 20: 75-79, 1998.
108. Gallimberti L, Spella MR, Soncini CA, and Gessa GL. Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20: 257-262, 2000.
109. Galvez T, Duthey B, Kniazeff J, Blahos J, Rovelli G, Bettler B, Prezeau L, and Pin JP. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA-B receptor function. EMBO J 20: 2152-2159, 2001.
110. Galvez T, Parmentier ML, Joly C, Malitschek B, Kaupmann K, Kuhn R, Bittiger H, Froestl W, Bettler B, and Pin JP. Mutagenesis and modeling of the GABA-B receptor extracellular domain support a venus flytrap mechanism for ligand binding. J Biol Chem 274: 13362-13369, 1999.
111. Galvez T, Prezeau L, Milioti G, Franek M, Joly C, Froestl W, Bettler B, Bertrand HO, Blahos J, and Pin JP. Mapping the agonist-binding site of GABA-B type 1 subunit sheds light on the activation process of GABA-B receptors. J Biol Chem 275: 41166-41174, 2000.
112. Galvez T, Urwyler S, Prezeau L, Mosbacher J, Joly C, Malitschek B, Heid J, Brabet I, Froestl W, Bettler B, Kaupmann K, and Pin JP. Ca(2+) requirement for high-affinity gamma-aminobutyric acid (GABA) binding at GABA-B receptors: involvement of serine 269 of the GABA-BR1 subunit. Mol Pharmacol 57: 419-426, 2000.
113. Gambardella A, Manna I, Labate A, Chifari R, La Russa A, Serra P, Cittadella R, Bonavita S, Andreoli V, Lepiane E, Sasanelli F, Di Costanzo A, Zappia M, Tedeschi G, Aguglia U, and Quattrone A. Gaba-B receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 60: 560-563, 2003.
114. Gasparini F, Kuhn R, and Pin JP. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr Opin Pharmacol 2: 43-49, 2002.
115. Gemignani A, Paudice P, Bonanno G, and Raiteri M. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes. Mol Pharmacol 46: 558-562, 1994.
116. + current, IAHP, by reducing adenylyl cyclase activity in rat CA3 hippocampal neurons. J Neurophysiol 72: 2360-2367, 1994.
117. Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, Canela EI, Rondin S, Lew JY, Watson S, Zoli M, Agnati LF, Verniera P, Lluis C, Ferre S, Fuxe K, and Franco R. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 97: 8606-8611, 2000.
118. Ginham R, Blein S, Barlow P, White J, and McIlhinney RA. Interaction of "Sushi" domain of GABA-BR1a subunit with the extracellular matrix protein fibulin. FENS Abstr 1: 144.146, 2002.
119. Gomeza J, Joly C, Kuhn R, Knopfel T, Bockaert J, and Pin JP. The second intracellular loop of metabotropic glutamate receptor 1 cooperates with the other intracellular domains to control coupling to G-proteins. J Biol Chem 271: 2199-2205, 1996.
120. Gomez-Villafuertes R, Pintor J, Gualix J, and Miras-Portugal MT. Gaba-B receptor-mediated presynaptic potentiation of ATP ionotropic receptors in rat midbrain synaptosomes. Neuropharmacology 44: 311-323, 2003.
121. Green A, Walls S, Wise A, Green RH, Martin AK, and Marshall FH. Characterization of [(3)H]-CGP54626A binding to heterodimeric GABA-B receptors stably expressed in mammalian cells. Br J Pharmacol 131: 1766-1774, 2000.
122. Greif GJ, Sodickson DL, Bean BP, Neer EJ, and Mende U. Altered regulation of potassium and calcium channels by GABA-B and adenosine receptors in hippocampal neurons from mice lacking Galpha(o). J Neurophysiol 83: 1010-1018, 2000.
123. Grifa A, Totaro A, Rommens JM, Carella M, Roetto A, Borgato L, Zelante L, and Gasparini P. Gaba (gamma-amino-butyric-acid) neurotransmission: identification and fine mapping of the human GABA-B receptor gene. Biochem Biophys Res Commun 250: 240-245, 1998.
124. Grobaski KC, Ping H, Dasilva HM, Bowery NG, Connelly ST, and Shepard PD. Responses of rat substantia nigra dopamine-containing neurones to (-)-HA-966 in vitro. Br J Pharmacol 120: 575-580, 1997.
125. Grunewald S, Schupp BJ, Ikeda SR, Kuner R, Steigerwald F, Kornau HC, and Kohr G. Importance of the gamma-aminobutyric acid B receptor C-termini for G-protein coupling. Mol Pharmacol 61: 1070-1080, 2002.
126. Guatteo E, Fusco FR, Giacomini P, Bernardi G, and Mercuri NB. The weaver mutation reverses the function of dopamine and GABA in mouse dopaminergic neurons. J Neurosci 20: 6013-6020, 2000.
127. Haas KZ, Sperber EF, Moshe SL, and Stanton PK. Kainic acid-induced seizures enhance dentate gyrus inhibition by down-regulation of GABA-B receptors. J Neurosci 16: 4250-4260, 1996.
128. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 53: 1083-1088, 1998.
129. 2+ receptors. Mol Pharmacol 55: 642-648, 1999.
130. Harayama N, Shibuya I, Tanaka K, Kabashima N, Ueta Y, and Yamashita H. Inhibition of N- and P/Q-type calcium channels by postsynaptic GABA-B receptor activation in rat supraoptic neurones. J Physiol 509: 371-383, 1998.
131. Harris BZ and Lim WA. Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 114: 3219-3231, 2001.
132. Harrison NL. On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones. J Physiol 422: 433-446, 1990.
133. Hashimoto T and Kuriyama K. In vivo evidence that GABA-B receptors are negatively coupled to adenylate cyclase in rat striatum. J Neurochem 69: 365-370, 1997.
134. Hausser MA and Yung WH. Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro. J Physiol 479: 401-422, 1994.
135. Hawrot E, Xiao Y, Shi QL, Norman D, Kirkitadze M, and Barlow PN. Demonstration of a tandem pair of complement protein modules in GABA-B receptor 1a. FEBSLett 432: 103-108, 1998.
136. He XB, Hu JH, Wu Q, Yan YC, and Koide SS. Identification of GABA-B receptor in rat testis and sperm. Biochem Biophys Res Commun 283: 243-247, 2001.
137. Heese K, Otten U, Mathivet P, Raiteri M, Marescaux C, and Bernasconi R. Gaba-B receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology 39: 449-462, 2000.
138. Heinemann U, Konnerth A, Pumain R, and Wadman WJ. Extracellular calcium and potassium concentration changes in chronic epileptic brain tissue. Adv Neurol 44: 641-661, 1986.
139. Hering-Hanit R. Baclofen for prevention of migraine. Cephalalgia 19: 589-591, 1999.
140. 2+ channels by G-protein beta gamma subunits. Nature 380: 258-262, 1996.
141. Herman RM, D'Luzansky SC, and Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 8: 338-345, 1992.
142. Heuss C and Gerber U. G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci 23: 469-475, 2000.
143. Heuss C, Scanziani M, Gahwiler BH, and Gerber U. G-protein-independent signaling mediated by metabotropic glutamate receptors. Nat Neurosci 2: 1070-1077, 1999.
144. Hill DR, Bowery NG, and Hudson AL. Inhibition of GABA-B receptor binding by guanyl nucleotides. J Neurochem 42: 652-657, 1984.
145. Hirono M, Yoshioka T, and Konishi S. Gaba-B receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Nat Neurosci 4: 1207-1216, 2001.
146. Hirsch DP, Tytgat GN, and Boeckxstaens GE. Transient lower oesophageal sphincter relaxations: a pharmacological target for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 16: 17-26, 2002.
147. Hosford DA, Clark S, Cao Z, Wilson WA, Lin FH, Morrisett RA Jr, and Huin A. The role of GABA-B receptor activation in absence seizures of lethargic (lh/lh) mice. Science 257: 398-401, 1992.
148. Hoshino M, Suzuki E, Nabeshima Y, and Hama C. Hikaru genki protein is secreted into synaptic clefts from an early stage of synapse formation in Drosophila. Development 122: 589-597, 1996.
149. Hsueh YP, Wang TF, Yang FC, and Sheng M. Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2. Nature 404: 298-302, 2000.
150. Hue B. Functional assay for GABA receptor subtypes of a cockroach giant interneuron. Arch Insect Biochem Physiol 18: 147-157, 1991.
151. Ige AO, Bolam JP, Billinton A, White JH, Marshall FH, and Emson PC. Cellular and sub-cellular localisation of GABA-B1 and GABA-B2 receptor proteins in the rat cerebellum. Brain Res 83: 72-80, 2000.
152. Ikeda SR. Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature 380: 255-258, 1996.
153. Inoue M, Matsuo T, and Ogata N. Characterization of pre- and postsynaptic actions of (-)-baclofen in the guinea-pig hippocampus in vitro. Br J Pharmacol 84: 843-851, 1985.
154. Ipponi A, Lamberti C, Medica A, Bartolini A, and Malmberg-Aiello P. Tiagabine antinociception in rodents depends on GABA-B receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis. Eur J Pharmacol 368: 205-211, 1999.
155. Isaacson JS, Solis JM, and Nicoll RA. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10: 165-175, 1993.
156. Isomoto S, Kaibara M, Sakurai-Yamashita Y, Nagayama Y, Uezono Y, Yano K, and Taniyama K. Cloning and tissue distribution of novel splice variants of the rat GABA-B receptor. Biochem Biophys Res Commun 253: 10-15, 1998.
157. B receptor in cultured cerebellar granule cells. J Neurochem 65: 75-83, 1995.
158. Iyadomi M, Iyadomi I, Kumamoto E, Tomokuni K, and Yoshimura M. Presynaptic inhibition by baclofen of miniature EPSCs and IPSCs in substantia gelatinosa neurons of the adult rat spinal dorsal horn. Pain 85: 385-393, 2000.
159. Jarolimek W, Bijak M, and Misgeld U. Differences in the Cs block of baclofen and 4-aminopyridine induced potassium currents of guinea pig CA3 neurons in vitro. Synapse 18: 169-177, 1994.
160. Jasmin L, Rabkin SD, Granato A, Boudah A, and Ohara PT. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 424: 316-320, 2003.
161. Jensen AA, Mosbacher J, Elg S, Lingenhoehl K, Lohmann T, Johansen TN, Abrahamsen B, Mattsson JP, Lehmann A, Bettler B, and Brauner-Osborne H. The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors. Mol Pharmacol 61: 1377-1384, 2002.
162. Jensen K and Mody I. Ghb depresses fast excitatory and inhibitory synaptic transmission via GABA-B receptors in mouse neocortical neurons. Cereb Cortex 11: 424-429, 2001.
163. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, and Gerald C. Gaba-B receptors function as a heteromeric assembly of the subunits GABA-BR1 and GABA-BR2. Nature 396: 674-679, 1998.
164. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, and Devi LA. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 98: 343-348, 2001.
165. Kalivas PW and Duffy P. D1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15: 5379-5388, 1995.
166. Kammerer RA, Frank S, Schulthess T, Landwehr R, Lustig A, and Engel J. Heterodimerization of a functional GABA-B receptor is mediated by parallel coiled-coil alpha-helices. Biochemistry 38: 13263-13269, 1999.
167. Kang J, Jiang L, Goldman SA, and Nedergaard M. Astrocyte-mediated potentiation of inhibitory synaptic transmission. Nat Neurosci 1: 683-692, 1998.
168. B(1)-deficient mice. Eur J Neurosci. 18: 2722-2730, 2003.
169. Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, Mcmaster G, Angst C, Bittiger H, Froestl W, and Bettler B. Expression cloning of GABA-B receptors uncovers similarity to metabotropic glutamate receptors. Nature 386: 239-246, 1997.
170. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kullik A, Shigemoto R, Karschin A, and Bettler B. Gaba-B receptor subtypes assemble into functional heteromeric complexes. Nature 396: 683-687, 1998.
171. + channels. Proc Natl Acad Sci USA 95: 14991-14996, 1998.
172. 3H]CGP 62349. Brain Res 71: 279-289, 1999.
173. Kelly MJ, Lagrange AH, Wagner EJ, and Ronnekleiv OK. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64: 64-75, 1999.
174. Kenakin T. Differences between natural and recombinant G-protein coupled receptor systems with varying receptor/G-protein stoichiometry. Trends Pharmacol Sci 18: 456-464, 1997.
175. Kerr DI, Ong J, Puspawati NM, and Prager RH. Arylalkylamines are a novel class of positive allosteric modulators at GABA-B receptors in rat neocortex. Eur J Pharmacol 451: 69-77, 2002.
176. Kitano J, Kimura K, Yamazaki Y, Soda T, Shigemoto R, Nakajima Y, and Nakanishi S. Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins. J Neurosci 22: 1280-1289, 2002.
177. Kittler JT, Rostaing P, Schiavo G, Fritschy JM, Olsen R, Triller A, and Moss SJ. The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA-A receptors. Mol Cell Neurosci 18: 13-25, 2001.
178. Knapp CM, Foye MM, Ciraulo DA, and Kornetsky C. The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Pharmacol Biochem Behav 62: 151-158, 1999.
179. Kniazeff J, Galvez T, Labesse G, and Pin JP. No ligand binding in the GB2 subunit of the GABA-B receptor is required for activation and allosteric interaction between the subunits. J Neurosci 22: 7352-7361, 2002.
180. Knoflach F, Mutel V, Jolidon S, Kew JN, Malherbe P, Vieira E, Wichmann J, and Kemp JA. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc Natl Acad Sci USA 98: 13402-13407, 2001.
181. Koek GH, Sifrim D, Lerut T, Janssens J, and Tack J. Effect of the GABA-B agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52: 1397-1402, 2003.
182. Kornau HC, Schenker LT, Kennedy MB, and Seeburg PH. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269: 1737-1740, 1995.
183. 2+-sensing function of the metabotropic glutamate receptors. Science 279: 1722-1725, 1998.
184. Kulik A, Nakadate K, Nyiri G, Notomi T, Malitschek B, Bettler B, and Shigemoto R. Distinct localization of GABA-B receptors relative to synaptic sites in the rat cerebellum and ventrobasal thalamus. Eur J Neurosci 15: 291-307, 2002.
185. Kuner R, Kohr G, Grunewald S, Eisenhardt G, Bach A, and Kornau HC. Role of heteromer formation in GABA-B receptor function. Science 283: 74-77, 1999.
186. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, Jingami H, and Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407: 971-977, 2000.
187. Kushner SA, Dewey SL, and Kornetsky C. The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290: 797-802, 1999.
188. Lacaille JC. Postsynaptic potentials mediated by excitatory and inhibitory amino acids in intemeurons of stratum pyramidale of the CA1 region of rat hippocampal slices in vitro. J Neurophysiol 66: 1441-1454, 1991.
189. Lagrange AH, Wagner EJ, Ronnekleiv OK, and Kelly MJ. Estrogen rapidly attenuates a GABA-B response in hypothalamic neurons. Neuroendocrinology 64: 114-123, 1996.
190. Lanneau C, Green A, Hirst WD, Wise A, Brown JT, Donnier E, Charles KJ, Wood M, Davies CH, and Pangalos MN. Gabapentin is not a GABA-B receptor agonist. Neuropharmacology 41: 965-975, 2001.
191. Lazarewicz JW. Calcium transients in brain ischemia: role in neuronal injury. Acta Neurobiol Exp 56: 299-311, 1996.
192. Leaney JL and Tinker A. The role of members of the pertussis toxin-sensitive family of G proteins in coupling receptors to the activation of the G protein-gated inwardly rectifying potassium channel. Proc Natl Acad Sci USA 97: 5651-5656, 2000.
193. Lehmann A, Bremner-Danielsen M, Branden L, and Karrberg L. Inhibitory effects of GABA-B receptor agonists on swallowing in the dog. Eur J Pharmacol 448: 67-70, 2002.
194. Liang F, Hatanaka Y, Saito H, Yamamori T, and Hashikawa T. Differential expression of gamma-aminobutyric acid type B receptor-1a and -1b mRNA variants in GABA and non-GABAergic neurons of the rat brain. J Comp Neurol 416: 475-495, 2000.
195. Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, and Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278: 21655-21662, 2003.
196. Lidums I, Lehmann A, Checklin H, Dent J, and Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA-B agonist baclofen in normal subjects. Gastroenterology 118: 7-13, 2000.
197. Ling W, Shoptaw S, and Majewska D. Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18: 403-404, 1998.
198. Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, Bettler B, and Mosbacher J. Gamma-hydroxybutyrate is a weak agonist at recombinant GABA-B receptors. Neuropharmacology 38: 1667-1673, 1999.
199. Lorente P, Lacampagne A, Pouzeratte Y, Richards S, Malitschek B, Kuhn R, Bettler B, and Vassort G. Gamma-aminobutyric acid type B receptors are expressed and functional in mammalian cardiomyocytes. Proc Natl Acad Sci USA 97: 8664-8669, 2000.
200. Lu XY, Ghasemzadeh MB, and Kalivas PW. Regional distribution and cellular localization of gamma-aminobutyric acid subtype 1 receptor mRNA in the rat brain. J Comp Neurol 407: 166-182, 1999.
201. + channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19: 687-695, 1997.
202. Maguire G, Maple B, Lukasiewicz P, and Werblin F. Gamma-aminobutyrate type B receptor modulation of L-type calcium channel current at bipolar cell terminals in the retina of the tiger salamander. Proc Natl Acad Sci USA 86: 10144-10147, 1989.
203. Mako E, Ronai AZ, Adam G, Juhasz G, Ritter L, Lestar B, and Crunelli V. Modulation by GABA-B and delta opioid receptors of neurally induced responses in isolated guinea-pig taenia coli and human colonic circular muscle. J Physiol 94: 135-138, 2000.
204. Malan TP, Mata HP, and Porreca F. Spinal GABA-A and GABA-B receptor pharmacology in a rat model of neuropathic pain. Anesthesiology 96: 1161-1167, 2002.
205. Malherbe P, Kratochwil N, Knoflach F, Zenner MT, Kew JN, Kratzeisen C, Maerki HP, Adam G, and Mutel V. Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, non-competitive antagonist of the metabotropic glutamate 1 receptor. J Biol Chem 278: 8340-8347, 2003.
206. Malitschek B, Rüegg D, Heid J, Kaupmann K, Bittiger H, Fröstl W, Bettler B, and Kuhn R. Developmental changes in agonist affinity at GABA-BR1 receptor variants in rat brain. Mol Cell Neurosci 12: 56-64, 1998.
207. Malitschek B, Schweizer C, Keir M, Heid J, Froestl W, Mosbacher J, Kuhn R, Henley J, Joly C, Pin JP, Kaupmann K, and Bettler B. The N-terminal domain of gamma-aminobutyric acid-B receptors is sufficient to specify agonist and antagonist binding. Mol Pharmacol 56: 448-454, 1999.
208. Marchetti C, Carignani C, and Robello M. Voltage-dependent calcium currents in dissociated granule cells from rat cerebellum. Neuroscience 43: 121-133, 1991.
209. Marescaux C, Vergnes M, Liu Z, Depaulis A, and Bernasconi R. Gaba-B receptor involvement in the control of genetic absence seizures in rats. Epilepsy Res Suppl 9: 131-138, 1992.
210. Margeta-Mitrovic M, Jan YN, and Jan LY. A trafficking checkpoint controls GABA-B receptor heterodimerization. Neuron 27: 97-106, 2000.
211. Margeta-Mitrovic M, Jan YN, and Jan LY. Function of GB1 and GB2 subunits in G protein coupling of GABA-B receptors. Proc Natl Acad Sci USA 98: 14649-14654, 2001.
212. Margeta-Mitrovic M, Jan YN, and Jan LY. Ligand-induced signal transduction within heterodimeric GABA-B receptor. Proc Natl Acad Sci USA 98: 14643-14648, 2001.
213. Margeta-Mitrovic M, Mitrovic I, Riley RC, Jan LY, and Basbaum AI. Immunohistochemical localization of GABA-B receptors in the rat central nervous system. J Comp Neurol 405: 299-321, 1999.
214. Marshall FH, Jones KA, Kaupmann K, and Bettler B. Gaba-B receptors: the first 7TM heterodimers. Trends Pharmacol Sci 20: 396-399, 1999.
215. Martellotta MC, Balducci C, Fattore L, Cossu G, Gessa GL, Pulvirenti L, and Fratta W. Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 59: 697-702, 1998.
216. Martin SC, Russek SJ, and Farb DH. Molecular identification of the human GABA-BR2: cell surface expression and coupling to adenylyl cyclase in the absence of GABA-BR1. Mol Cell Neurosci 13: 180-191, 1999.
217. Martin SC, Russek SJ, and Farb DH. Human GABA-BR genomic structure: evidence for splice variants in GABA-BR1 but not GABA-BR2. Gene 278: 63-79, 2001.
218. Masu M, Tanabe Y, Tsuchida K, Shigemoto R, and Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature 349: 760-765, 1991.
219. 2+ currents, postinhibitory rebound, and postspike afterhyperpolarization in lamprey neurons. J Neurophysiol 70: 2606-2619, 1993.
220. McCormick DA. GABA as an inhibitory neurotransmitter in human cerebral cortex. J Neurophysiol 62: 1018-1027, 1989.
221. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM. Ramps regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339, 1998.
222. Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, Yamazaki M, Kumanishi T, Arakawa M, Sakimura K, and Mishina M. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357: 70-74, 1992.
223. Menon-Johansson AS, Berrow N, and Dolphin AC. G(o) transduces GABA-B receptor modulation of N-type calcium channels in cultured dorsal root ganglion neurons. Pflügers Arch 425: 335-343, 1993.
224. Mezler M, Muller T, and Raming K. Cloning and functional expression of GABA-B receptors from Drosophila. Eur J Neurosci 13: 477-486, 2001.
225. 2+ channels in central neurons. Neuron 10: 889-898, 1993.
226. Miwa A, Ui M, and Kawai N. G protein is coupled to presynaptic glutamate and GABA receptors in lobster neuromuscular synapse. J Neurophysiol 63: 173-180, 1990.
227. Mondadori C, Moebius HJ, and Zingg M. Cgp36742, an orally active GABA-B receptor antagonist, facilitates memory in a social recognition test in rats. Behav Brain Res 77: 227-229, 1996.
228. Morishita R, Kato K, and Asano T. Gaba-B receptors couple to G proteins Go, Go* and Gi1 but not to Gi2. FEBS Lett 271: 231-235, 1990.
229. Mott DD and Lewis DV. Facilitation of the induction of long-term potentiation by GABA-B receptors. Science 252: 1718-1720, 1991.
230. Mouginot D, Kombian SB, and Pittman QJ. Activation of presynaptic GABA-B receptors inhibits evoked IPSCs in rat magnocellular neurons in vitro. J Neurophysiol 79: 1508-1517, 1998.
231. Munoz A, Defelipe J, and Jones EG. Patterns of GABA-BR1a,b receptor gene expression in monkey and human visual cortex. Cereb Cortex 11: 104-113, 2001.
232. Munoz A, Huntsman MM, and Jones EG. Gaba-B receptor gene expression in monkey thalamus. J Comp Neurol 394: 118-126, 1998.
233. Nakayasu H, Nishikawa M, Mizutani H, Kimura H, and Kuriyama K. Immunoaffinity purification and characterization of gamma-aminobutyric acid (GABA) B receptor from bovine cerebral cortex. J Biol Chem 268: 8658-8664, 1993.
234. 2+ in single cells. J Biol Chem 276: 19286-19293, 2001.
235. Nehring RB, Horikawa HP, El Far O, Kneussel M, Brandstatter JH, Stamm S, Wischmeyer E, Betz H, and Karschin A. The metabotropic GABA-B receptor directly interacts with the activating transcription factor 4. J Biol Chem 275: 35185-35191, 2000.
236. Newberry NR and Nicoll RA. Comparison of the action of baclofen with gamma-aminobutyric acid on rat hippocampal pyramidal cells in vitro. J Physiol 360: 161-185, 1985.
237. Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, Belley M, Trimble L, Bateman K, Alder L, Smith A, McKernan R, Metters K, O'Neill GP, Lacaille JC, and Hebert TE. Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 59: 144-152, 2001.
238. Ng GY, McDonald T, Bounert T, Rigby M, Heavens R, Whiting P, Chateauneuf A, Coulombe N, Kargman S, Caskey T, Evans J, O'Neill GP, and Liu Q. Cloning of a novel G-protein-coupled receptor GPR 51 resembling GABA-B receptors expressed predominantly in nervous tissues and mapped proximal to the hereditary sensory neuropathy type 1 locus on chromosome 9. Genomics 56: 288-295, 1999.
239. Ng GYK, Clark J, Coulombe N, Ethier N, Hebert TE, Sullivan R, Kargman S, Chateauneuf A, Tsukamoto N, McDonald T, Whiting P, Mezey E, Johnson Mp Liu Q, Kolakowski LF, Evans JF, Bonner TI, and O'Neill GP. Identification of a GABA-B receptor subunit, gb2, required for functional GABA-B receptor activity. J Biol Chem 274: 7607-7610, 1999.
240. Ng TK and Yung KK. Subpopulations of neurons in rat substantia nigra display GABA-BR2 receptor immunoreactivity. Brain Res 920: 210-216, 2001.
241. Nicholson KL and Balster RL. Ghb: a new and novel drug of abuse. Drug Alcohol Depend 63: 1-22, 2001.
242. o evoked by baclofen in guinea pig hippocampus. Can J Physiol Pharmacol 76: 148-154, 1998.
243. + conductances induced by baclofen and gamma-aminobutyric acid in slices of the guinea pig hippocampus. Synapse 1: 62-69, 1987.
244. Okamoto T, Sekiyama N, Otsu M, Shimada Y, Sato A, Nakanishi S, and Jingami H. Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. J Biol Chem 273: 13089-13096, 1998.
245. Olah GA, Trakhanov S, Trewhella J, and Quiocho FA. Leucine/ isoleucine/valine-binding protein contracts upon binding of ligand. J Biol Chem 268: 16241-16247, 1993.
246. Olpe HR, Karlsson G, Pozza MF, Brugger F, Steinmann M, Van Riezen H, Fagg G, Hall RG, Froestl W, and Bittiger H. Cgp 35348: a centrally active blocker of GABA-B receptors. Eur J Pharmacol 187: 27-38, 1990.
247. Olpe HR, Woerner W, and Ferrat T. Stimulation parameters determine role of GABA-B receptors in long-term potentiation. Experientia 49: 542-546, 1993.
248. Ong J, Marino V, Parker DA, and Kerr DI. Differential effects of phosphonic analogues of GABA on GABA-B autoreceptors in rat neocortical slices. Naunyn-Schmiedebergs Arch Pharmacol 357: 408-412, 1998.
249. Otis TS, De Koninck Y, and Mody I. Characterization of synaptically elicited GABA-B responses using patch-clamp recordings in rat hippocampal slices. J Physiol 463: 391-407, 1993.
250. Pagano A, Rovelli G, Mosbacher J, Lohmann T, Duthey B, Stauffer D, Ristig D, Schuler V, Meigel I, Lampert C, Stein T, Prezeau L, Blahos J, Pin J, Froestl W, Kuhn R, Heid J, Kaupmann K, and Bettler B. C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA-B receptors. J Neurosci 21: 1189-1202, 2001.
251. Pagano A, Ruegg D, Litschig S, Stoehr N, Stierlin C, Heinrich M, Floersheim P, Prezeau L, Carroll F, Pin JP, Cambria A, Vranesic I, Flor PJ, Gasparini F, and Kuhn R. The non-competitive antagonists 2-methyl-6- (phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors. J Biol Chem 275: 33750-33758, 2000.
252. Paredes RG and Agmo A. The GABA-B antagonist CGP 35348 inhibits the effects of baclofen on sexual behavior and motor coordination. Brain Res Bull 36: 495-497, 1995.
253. Parmentier ML, Prezeau L, Bockaert J, and Pin JP. A model for the functioning of family 3 GPCRs. Trends Pharmacol Sci 23: 268-274, 2002.
254. Parnas I, Rashkovan G, Ong J, and Kerr DI. Tonic activation of presynaptic GABA-B receptors in the opener neuromuscular junction of crayfish. J Neurophysiol 81: 1184-1191, 1999.
255. Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, and Fox A. The effects of GABA-B agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain 90: 217-226, 2001.
256. Pearson H. Surviving a knockout blow. Nature 415: 8-9, 2002.
257. Pehrson R, Lehmann A, and Andersson KE. Effects of gamma-aminobutyrate B receptor modulation on normal micturition and oxyhemoglobin induced detrusor overactivity in female rats. J Urol 168: 2700-2705, 2002.
258. Perroy J, Adam L, Qanbar R, Chenier S, and Bouvier M. Phosphorylation-independent desensitization of GABA-B receptor by GRK4. EMBO J 22: 3816-3824, 2003.
259. Peters HC, Kämmer G, Volz A, Kaupmann K, Ziegler A, Bettler B, Epplen JT, Sander T, and Riess O. Mapping, genomic structure, and polymorphisms of the human GABAB-R1 receptor gene: evaluation of its involvement in idiopathic generalized epilepsy. Neurogenetics 2: 47-54, 1998.
260. Pfaff T, Malitschek B, Kaupmann K, Prezeau L, Pin JP, Bettler B, and Karschin A. Alternative splicing generates a novel isoform of the rat metabotropic GABAB-R1 receptor. Eur J Neurosci 11: 2874-2882, 1999.
261. Pfrieger FW, Gottmann K, and Lux HD. Kinetics of GABA-B receptor-mediated inhibition of calcium currents and excitatory synaptic transmission in hippocampal neurons in vitro. Neuron 12: 97-107, 1994.
262. Phelan KD. N-ethylmaleimide selectively blocks presynaptic GABA-B autoreceptor but not heteroreceptor-mediated inhibition in adult rat striatal slices. Brain Res 847: 308-313, 1999.
263. Pin JP, Parmentier ML, and Prezeau L. Positive allosteric modulators for gamma-aminobutyric acid-B receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors. Mol Pharmacol 60: 881-884, 2001.
264. Pitler TA and Alger BE. Differences between presynaptic and postsynaptic GABA-B mechanisms in rat hippocampal pyramidal cells. J Neurophysiol 72: 2317-2327, 1994.
265. Poncer JC, McKinney RA, Gahwiler BH, and Thompson SM. Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses. Neuron 18: 463-472, 1997.
266. Poncer JC, McKinney RA, Gahwiler BH, and Thompson SM. Differential control of GABA release at synapses from distinct interneurons in rat hippocampus. J Physiol 528: 123-130, 2000.
267. Poorkhalkali N, Juneblad K, Jonsson AC, Lindberg M, Karlsson O, Wallbrandt P, Ekstrand J, and Lehmann A. Immunocytochemical distribution of the GABA-B receptor splice variants GABA-B R1a and R1b in the rat CNS and dorsal root ganglia. Anat Embryol 201: 1-13, 2000.
268. Pozza MF, Manuel NA, Steinmann M, Froestl W, and Davies CH. Comparison of antagonist potencies at pre- and post-synaptic GABA-B receptors at inhibitory synapses in the CA1 region of the rat hippocampus. Br J Pharmacol 127: 211-219, 1999.
269. Prezeau L, Richman JG, Edwards SW, and Limbird LE. The zeta isoform of 14-3-3 proteins interacts with the third intracellular loop of different alpha2-adrenergic receptor subtypes. J Biol Chem 274: 13462-13469, 1999.
270. Princivalle A, Spreafico R, Bowery N, and De Curtis M. Layer-specific immunocytochemical localization of GABA-BR1a and GABA-BR1b receptors in the rat piriform cortex. Eur J Neurosci 12: 1516-1520, 2000.
271. Princivalle AP, Pangalos MN, Bowery NG, and Spreafico R. Distribution of GABA-B1a, GABA-B1b and GABA-B2 receptor protein in cerebral cortex and thalamus of adult rats. Neuroreport 12: 591-595, 2001.
272. Prosser HM, Gill CH, Hirst WD, Grau E, Robbins M, Calver A, Soffin EM, Farmer CE, Lanneau C, Gray J, Schenck E, Warmerdam BS, Clapham C, Reavill C, Rogers DC, Stean T, Upton N, Humphreys K, Randall A, Geppert M, Davies CH, and Pangalos MN. Epileptogenesis and enhanced prepulse inhibition in GABA-B1 deficient mice. Mol Cell Neurosci 17: 1059-1070, 2001.
273. Przesmycki K, Dzieciuch JA, Czuczwar SJ, and Kleinrok Z. An isobolographic analysis of drug interaction between intrathecal clonidine and baclofen in the formalin test in rats. Neuropharmacology 37: 207-214, 1998.
274. Quéva C, Bremner-Danielsen M, Edlund A, Ekstrand AJ, Elg S, Erickson S, Johannson T, Lehmann A, and Mattsson JP. Effects of GABA agonists on body temperature regulation in GABA-B1-/- mice. Br J Pharmacol: 1-8, 2003.
275. Quiocho FA and Ledvina PS. Atomic structure and specificity of bacterial periplasmic receptors for active transport and chemotaxis: variation of common themes. Mol Microbiol 20: 17-25, 1996.
276. Rathmayer W and Djokaj S. Presynaptic inhibition and the participation of GABA-B receptors at neuromuscular junctions of the crab Eriphia spinifrons. J Comp Physiol 186: 287-298, 2000.
277. Ratomponirina C, Hode Y, Hechler V, and Maitre M. Gamma-hydroxybutyrate receptor binding in rat brain is inhibited by guanyl nucleotides and pertussis toxin. Neurosci Lett 189: 51-53, 1995.
278. Ray K and Hauschild BC. Cys-140 is critical for metabotropic glutamate receptor-1 dimerization. J Biol Chem 275: 34245-34251, 2000.
279. Ren X and Mody I. Gamma-hydroxybutyrate (GHB) reduces MAP kinase phosphorylation via GABA-B receptor activation in mouse frontal cortex and hippocampus. J Biol Chem 15: 15, 2003.
280. Robbins MJ, Calver AR, Filippov AK, Hirst WD, Russell RB, Wood MD, Nasir S, Couve A, Brown DA, Moss SJ, and Pangalos MN. Gaba-B2 is essential for G-protein coupling of the GABA-B receptor heterodimer. J Neurosci 21: 8043-8052, 2001.
281. Robbins MJ, Michalovich D, Hill J, Calver AR, Medhurst AD, Gloger I, Sims M, Middlemiss DN, and Pangalos MN. Molecular cloning and characterization of two novel retinoic acid-inducible orphan G-protein coupled receptors (GPRC5B and GPRC5C). Genomics 67: 8-18, 2000.
282. Roberts DC, Andrews MM, and Vickers GJ. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15: 417-423, 1996.
283. Robinson R, Taske N, Sander T, Heils A, Whitehouse W, Goutieres F, Aicardi J, Lehesjoki AE, Siren A, Lane Friis M, Kjeldsen MJ, Panayiotopoulos C, Kennedy C, Ferrie C, Rees M, and Gardiner RM. Linkage analysis between childhood absence epilepsy and genes encoding GABA-A and GABA-B receptors, voltage-dependent calcium channels, and the ECA1 region on chromosome 8q. Epilepsy Res 48: 169-179, 2002.
284. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, and Patel YC. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288: 154-157, 2000.
285. Rohrbacher J, Jarolimek W, Lewen A, and Misgeld U. Gaba-B receptor-mediated inhibition of spontaneous inhibitory synaptic currents in rat midbrain culture. J Physiol 500: 739-749, 1997.
286. Romano C, Yang WL, and O'Malley L. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem 271: 28612-28616, 1996.
287. Rubakhin SS, Szucs A, Gurin VN, and Rozsa KS. Inhibition of calcium spikes by gamma-amino-butyric acid in the neurons of Lymnaea stagnalis L. Acta Biol Hung 46: 375-380, 1995.
288. Saghatelyan AK, Snapyan M, Gorissen S, Meigel I, Mosbacher J, Kaupmann K, Bettler B, Kornilav AV, Nifantiev NE, Sakanyan V, Schachner M, and Dityatev A. Recognition molecule associated carbohydrate inhibits postsynaptic GABA-B receptors: a mechanism for homeostatic regulation of GABA release in perisomatic synapses. Mol Cell Neurosci 24: 271-282, 2003.
289. Saint DA, Thomas T, and Gage PW. Gaba-B agonists modulate a transient potassium current in cultured mammalian hippocampal neurons. Neurosci Lett 118: 9-13, 1990.
290. Sakaba T and Neher E. Direct modulation of synaptic vesicle priming by GABA-B receptor activation at a glutamatergic synapse. Nature 424: 775-778, 2003.
291. Sand PG, Godau C, Riederer P, Peters C, Franke P, Nothen MM, Stober G, Fritze J, Maier W, Propping P, Lesch KP, Riess O, Sander T, Beckmann H, and Deckert J. Exonic variants of the GABA-B receptor gene and panic disorder. Psychiatr Genet 10: 191-194, 2000.
292. Sander T, Peters C, Kammer G, Samochowiec J, Zirra M, Mischke D, Ziegler A, Kaupmann K, Bettler B, Epplen JT, and Riess O. Association analysis of exonic variants of the gene encoding the GABA-B receptor and idiopathic generalized epilepsy. Am J Med Genet 88: 305-310, 1999.
293. Sanger GJ, Munonyara ML, Dass N, Prosser H, Pangalos MN, and Parsons ME. Gaba-B receptor function in the ileum and urinary bladder of wildtype and GABA-B1 subunit null mice. Auton Autacoid Pharmacol 22: 147-154, 2002.
294. 2+] and GABA release by presynaptic GABA-B receptors in rat cerebrocortical synaptosomes. Neurochem Int 27: 397-406, 1995.
295. Sattelle DB, Pinnock RD, Wafford KA, and David JA. GABA receptors on the cell-body membrane of an identified insect motor neuron. Proc R Soc Lond B Biol Sci 232: 443-456, 1988.
296. 2+ on type 1alpha metabotropic glutamate receptor-mediated signalling. Neuropharmacology 37: 273-276, 1998.
297. Sauter K, Kaupmann K, Bettler B, Mohler H, and Benke D. Direct interaction of GABA-B receptors with the transcription factor CHOP. FENS Abstr 1: 144.112, 2001.
298. Scanziani M, Debanne D, Muller M, Gahwiler BH, and Thompson SM. Role of excitatory amino acid and GABA-B receptors in the generation of epileptiform activity in disinhibited hippocampal slice cultures. Neuroscience 61: 823-832, 1994.
299. 2+ currents and synaptic transmission in cultured rat hippocampal neurones. J Physiol 444: 669-686, 1991.
300. Schuler V, Luscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, Froestl W, Kaslin E, Korn R, Bischoff S, Kaupmann K, Van Der Putten H, and Bettler B. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA-B responses in mice lacking GABA-B1. Neuron 31: 47-58, 2001.
301. Schwarz DA, Barry G, Eliasof SD, Petroski RE, Conlon PJ, and Maki RA. Characterization of gamma-aminobutyric acid receptor GABA-Ble, a GABA-B1 splice variant encoding a truncated receptor. J Biol Chem 275: 32174-32181, 2000.
302. Scott DB, Blanpied TA, Swanson GT, Zhang C, and Ehlers MD. An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J Neurosci 21: 3063-3072, 2001.
303. Scott RH and Dolphin AC. Regulation of calcium currents by a GTP analogue: potentiation of (-)-baclofen-mediated inhibition. Neurosci Lett 69: 59-64, 1986.
304. Scott RH, Wootton JF, and Dolphin AC. Modulation of neuronal T-type calcium channel currents by photoactivation of intracellular guanosine 5′-O-(3-thio)triphosphate. Neuroscience 38: 285-294, 1990.
305. Seidenbecher T and Pape HC. Contribution of intralaminar thalamic nuclei to spike-and-wave-discharges during spontaneous seizures in a genetic rat model of absence epilepsy. Eur J Neurosci 13: 1537-1546, 2001.
306. + channels, through GTP-binding proteins. Brain Res 8: 301-309, 1990.
307. Serrats J, Artigas F, Mengod G, and Cortes R. Gaba-B receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. J Neurochem 84: 743-752, 2003.
308. Shen KZ and Johnson SW. Presynaptic GABA-B and adenosine Al receptors regulate synaptic transmission to rat substantia nigra reticulata neurones. J Physiol 505: 153-163, 1997.
309. Shen W and Slaughter MM. Metabotropic GABA receptors facilitate L-type and inhibit N-type calcium channels in single salamander retinal neurons. J Physiol 516: 711-718, 1999.
310. Shoaib M, Swanner LS, Beyer CE, Goldberg SR, and Schindler CW. The GABA-B agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol 9: 195-206, 1998.
311. Simonds WF. G protein regulation of adenylate cyclase. Trends Pharmacol Sci 20: 66-73, 1999.
312. Sindrup SH and Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 18: 22-27, 2002.
313. Sloviter RS, Ali-Akbarian L, Elliott RC, Bowery BJ, and Bowery NG. Localization of GABA-BR1 receptors in the rat hippocampus by immunocytochemistry and high resolution autoradiography, with specific reference to its localization in identified hippocampal interneuron subpopulations. Neuropharmacology 38: 1707-1721, 1999.
314. Smith BR, Boyle AE, and Amit Z. The effects of the GABA-B agonist baclofen on the temporal and structural characteristics of ethanol intake. Alcohol 17: 231-240, 1999.
315. Snead OC III. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 75: 1986-1996, 2000.
316. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, and Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol 11: 279-290, 2000.
317. Stringer JL and Lorenzo N. The reduction in paired-pulse inhibition in the rat hippocampus by gabapentin is independent of GABA-B receptor activation. Epilepsy Res 33: 169-176, 1999.
318. Symonds E, Butler R, and Omari T. The effect of the GABA-B receptor agonist baclofen on liquid and solid gastric emptying in mice. Eur J Pharmacol 470: 95-97, 2003.
319. Taira T, Kawamura H, Tanikawa T, Iseki H, Kawabatake H, and Takakura K. A new approach to control central deafferentation pain: spinal intrathecal baclofen. Stereotact Funct Neurosurg 65: 101-105, 1995.
320. Takahashi T, Kajikawa Y, and Tsujimoto T. G-protein-coupled modulation of presynaptic calcium currents and transmitter release by a GABA-B receptor. J Neurosci 18: 3138-3146, 1998.
321. Tang WJ and Gilman AG. Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science 254: 1500-1503, 1991.
322. Taniyama K, Niwa M, Kataoka Y, and Yamashita K. Activation of protein kinase C suppresses the gamma-aminobutyric acid-B receptor-mediated inhibition of the vesicular release of noradrenaline and acetylcholine. J Neurochem 58: 1239-1245, 1992.
323. Teoh H, Malcangio M, and Bowery NG. Gaba, glutamate and substance P-like immunoreactivity release: effects of novel GABA-B antagonists. Br J Pharmacol 118: 1153-1160, 1996.
324. Thompson JD, Higgins DG, and Gibson TJ. Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680, 1994.
325. Thompson SM and Gahwiler BH. Comparison of the actions of baclofen at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol 451: 329-345, 1992.
326. Towers S, Princivalle A, Billinton A, Edmunds M, Bettler B, Urban L, Castro-Lopes J, and Bowery NG. Gaba-B receptor protein and mRNA distribution in rat spinal cord and dorsal root ganglia. Eur J Neurosci 12: 3201-3210, 2000.
327. Tsao P and Von Zastrow M. Downregulation of G protein-coupled receptors. Curr Opin Neurobiol 10: 365-369, 2000.
328. Tsuji Y, Shimada Y, Takeshita T, Kajimura N, Nomura S, Sekiyama N, Otomo J, Usukura J, Nakanishi S, and Jingami H. Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1. J Biol Chem 275: 28144-28151, 2000.
329. Tunnicliff G and Raess BU. Gamma-hydroxybutyrate (orphan medical). Curr Opin Invest Drugs 3: 278-283, 2002.
330. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, and Kaupmann K. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid-B receptors by 2,6-Di-tert-butyl-4-(3- hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 60: 963-971, 2001.
331. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, and Kaupmann K. GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5- nitro-pyrimidine-4,6-diamine) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acid-B receptor function. J Pharmacol Exp Ther 3: 3, 2003.
332. Vergnes M, Boehrer A, Simler S, Bernasconi R, and Marescaux C. Opposite effects of GABA-B receptor antagonists on absences and convulsive seizures. Eur J Pharmacol 332: 245-255, 1997.
333. Vernon E, Meyer G, Pickard L, Dev K, Molnar E, Collingridge GL, and Henley JM. Gaba-B receptors couple directly to the transcription factor ATF4. Mol Cell Neurosci 17: 637-645, 2001.
334. Vogt KE and Nicoll RA. Glutamate and gamma-aminobutyric acid mediate a heterosynaptic depression at mossy fiber synapses in the hippocampus. Proc Natl Acad Sci USA 96: 1118-1122, 1999.
335. Wachowiak M and Cohen LB. Presynaptic inhibition of primary olfactory afferents mediated by different mechanisms in lobster and turtle. J Neurosci 19: 8808-8817, 1999.
336. Waldmeier PC, Wicki P, Feldtrauer JJ, Mickel SJ, Bittiger H, and Baumann PA. GABA and glutamate release affected by GABA-B receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. Br J Pharmacol 113: 1515-1521, 1994.
337. Walker RJ, Brooks HL, and Holden-Dye L. Evolution and overview of classical transmitter molecules and their receptors. Parasitology 113: S3-S33, 1996.
338. Wegelius K, Halonen T, and Korpi ER. Gamma-vinyl GABA decreases voluntary alcohol consumption in alcohol-preferring AA rats. Pharmacol Toxicol 73: 150-152, 1993.
339. Wei K, Eubanks JH, Francis J, Jia Z, and Snead OC III. Cloning and tissue distribution of a novel isoform of the rat GABA-BR1 receptor subunit. Neuroreport 12: 833-837, 2001.
340. Wei K, Jia Z, Wang YT, Yang J, Liu CC, and Snead OC III. Cloning and characterization of a novel variant of rat GABA-BR1 with a truncated C-terminus. Brain Res 89: 103-110, 2001.
341. White JH, Ginham R, Pontier S, Wise A, Blein S, Barlow P, Bouvier M, and McIlhinney RA. The heterodimeric GABA-B receptor and associated proteins. FENS Abstr 1: 062.061, 2002.
342. White JH, McIllhinney RA, Wise A, Ciruela F, Chan WY, Emson PC, Billinton A, and Marshall FH. The GABA-B receptor interacts directly with the related transcription factors CREB2 and ATFx. Proc Natl Acad Sci USA 97: 13967-13972, 2000.
343. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, and Marshall FH. Heterodimerization is required for the formation of a functional GABA-B receptor. Nature 396: 679-682, 1998.
344. Wiesenfeld-Hallin Z, Aldskogius H, Grant G, Hao JX, Hokfelt T, and Xu XJ. Central inhibitory dysfunctions: mechanisms and clinical implications. Behav Brain Sci 20: 420-425, 1997.
345. Wise A, Green A, Main MJ, Wilson R, Fraser N, and Marshall FH. Calcium sensing proper-ties of the GABA-B receptor. Neuropharmacology 38: 1647-1656, 1999.
346. Wise RA, Leone P, Rivest R, and Leeb K. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse 21: 140-148, 1995.
347. Wise RA, Newton P, Leeb K, Burnette B, Pocock D, and Justice JB Jr. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology 120: 10-20, 1995.
348. Wu C and Leung LS. Partial hippocampal kindling decreases efficacy of presynaptic GABA-B autoreceptors in CA1. J Neurosci 17: 9261-9269, 1997.
349. Wu LG and Saggau P. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20: 204-212, 1997.
350. Xi ZX, Ramamoorthy S, Shen H, Lake R, Samuvel DJ, and Kalivas PW. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci 23: 3498-3505, 2003.
351. Xi ZX and Stein EA. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther 290: 1369-1374, 1999.
352. Yamada K, Yu B, and Gallagher JP. Different subtypes of GABA-B receptors are present at pre- and postsynaptic sites within the rat dorsolateral septal nucleus. J Neurophysiol 81: 2875-2883, 1999.
353. Yoshimura M, Yoshida S, and Taniyama K. Desensitization by cyclic AMP-dependent protein kinase of GABA-B receptor expressed in Xenopus oocytes. Life Sci 57: 2397-2401, 1995.
354. Zamponi GW, Bourinet E, Nelson D, Nargeot J, and Snutch TP. Crosstalk between G proteins and protein kinase C mediated by the calcium channel alphal subunit. Nature 385: 442-446, 1997.
355. Zerangue N, Schwappach B, Jan YN, and Jan LY. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22: 537-548, 1999.
356. Zhang C, Bettler B, and Duvoisin RM. Differential localization of GABA-B receptors in the mouse retina. Neuroreport 9: 3493-3497, 1998.